X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (23104) 23104
Newsletter (2809) 2809
Newspaper Article (256) 256
Book Chapter (141) 141
Dissertation (30) 30
Magazine Article (20) 20
Book / eBook (17) 17
Publication (17) 17
Conference Proceeding (11) 11
Web Resource (9) 9
Reference (5) 5
Streaming Video (3) 3
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (16608) 16608
acute lymphocytic leukemia (8481) 8481
oncology (8312) 8312
cancer (8233) 8233
male (7753) 7753
hematology (7709) 7709
female (7517) 7517
research (6071) 6071
leukemia (5731) 5731
adult (5149) 5149
acute lymphoblastic-leukemia (4728) 4728
child (4651) 4651
adolescent (4394) 4394
middle aged (4239) 4239
acute myeloid-leukemia (4006) 4006
chemotherapy (3517) 3517
care and treatment (3409) 3409
child, preschool (3197) 3197
aged (3112) 3112
children (3100) 3100
oncology, experimental (3054) 3054
genetic aspects (2994) 2994
animals (2930) 2930
prognosis (2670) 2670
pediatrics (2553) 2553
health aspects (2479) 2479
acute lymphoblastic leukemia (2439) 2439
risk factors (2197) 2197
analysis (2146) 2146
chronic lymphocytic-leukemia (2136) 2136
infant (2093) 2093
transplantation (2020) 2020
acute disease (1985) 1985
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (1938) 1938
apoptosis (1869) 1869
acute lymphocytic-leukemia (1770) 1770
therapy (1701) 1701
expression (1692) 1692
stem cells (1664) 1664
precursor cell lymphoblastic leukemia-lymphoma - genetics (1635) 1635
treatment outcome (1623) 1623
gene expression (1577) 1577
mice (1556) 1556
diagnosis (1526) 1526
antineoplastic combined chemotherapy protocols - therapeutic use (1463) 1463
t cells (1458) 1458
acute myeloid leukemia (1448) 1448
immunology (1445) 1445
bone marrow (1325) 1325
acute lymphatic leukemia (1315) 1315
medicine & public health (1309) 1309
cell biology (1284) 1284
young adult (1275) 1275
mutation (1267) 1267
antineoplastic agents - therapeutic use (1259) 1259
hemic and lymphatic diseases (1243) 1243
hematopoietic stem cells (1232) 1232
precursor cell lymphoblastic leukemia-lymphoma - pathology (1151) 1151
proteins (1107) 1107
acute myelogenous leukemia (1102) 1102
patients (1093) 1093
flow cytometry (1088) 1088
cell line, tumor (1076) 1076
minimal residual disease (1075) 1075
retrospective studies (1075) 1075
lymphomas (1071) 1071
lymphatic leukemia (1065) 1065
survival (1063) 1063
lymphoma (1039) 1039
precursor cell lymphoblastic leukemia-lymphoma - therapy (1036) 1036
remission induction (1035) 1035
drug therapy (1028) 1028
genes (1025) 1025
physical fitness (1024) 1024
leukemia, myeloid, acute - drug therapy (1021) 1021
aged, 80 and over (1005) 1005
leukemia, myeloid, acute - genetics (1004) 1004
childhood (999) 999
physiological aspects (999) 999
biochemistry & molecular biology (971) 971
pharmacology & pharmacy (971) 971
recurrence (966) 966
risk (966) 966
genetics & heredity (943) 943
relapse (929) 929
hematology, oncology and palliative medicine (899) 899
bone-marrow-transplantation (898) 898
development and progression (889) 889
immunotherapy (889) 889
tumors (886) 886
medicine, research & experimental (871) 871
cells (862) 862
leukemia, myeloid, acute - pathology (857) 857
medical research (828) 828
antineoplastic agents (804) 804
patient outcomes (786) 786
pathology (756) 756
gene (753) 753
genetic research (750) 750
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (8) 8
Media Commons - Microtexts (1) 1
OISE - Theses (1) 1
Online Resources - Online (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (25869) 25869
Japanese (153) 153
Chinese (120) 120
French (96) 96
German (91) 91
Spanish (77) 77
Russian (29) 29
Polish (23) 23
Korean (20) 20
Portuguese (18) 18
Turkish (15) 15
Italian (14) 14
Dutch (6) 6
Serbian (5) 5
Czech (4) 4
Danish (4) 4
Hungarian (4) 4
Bulgarian (2) 2
Persian (2) 2
Arabic (1) 1
Croatian (1) 1
Greek (1) 1
Hebrew (1) 1
Norwegian (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Cancer, ISSN 0008-543X, 2013, Volume 119, Issue 15, pp. 2728 - 2736
Journal Article
2008, Hematologic malignancies, ISBN 3540723021, x, 294
Better therapy of acute leukemias depends ultimately on better understanding of the distinction between leukemic and normal progenitor cells... 
Leukemia, Myeloid, Acute | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Acute leukemia | Clinical & internal medicine
Book
The Journal of clinical investigation, ISSN 0021-9738, 2007, Volume 117, Issue 9, pp. 2408 - 2421
...) acute lymphocytic leukemia (ALL) are 2 fatal BCR/ABL-driven leukemias against which Abl kinase inhibitors fail to induce a long-term response... 
MEDICINE, RESEARCH & EXPERIMENTAL | SIGNALING PATHWAYS | POLYMERASE-CHAIN-REACTION | ABL TYROSINE KINASE | ACUTE LYMPHOBLASTIC-LEUKEMIA | BCR-ABL | IMMUNOSUPPRESSIVE AGENT | FUSION GENE | PROTEIN PHOSPHATASE 2A | TUMOR-GROWTH | CHRONIC MYELOID-LEUKEMIA | Phosphorylation | Blast Crisis - drug therapy | Humans | Phosphoprotein Phosphatases - metabolism | Gene Expression Regulation, Neoplastic | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Time Factors | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Propylene Glycols - therapeutic use | Molecular Structure | Tumor Cells, Cultured | Protein Phosphatase 2 | Cell Survival - drug effects | Dasatinib | Blast Crisis - pathology | Fingolimod Hydrochloride | Pyrimidines - pharmacology | Imatinib Mesylate | Piperazines - pharmacology | Fusion Proteins, bcr-abl - genetics | Sphingosine - analogs & derivatives | Animals | Signal Transduction - drug effects | Propylene Glycols - chemistry | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism | Sphingosine - therapeutic use | Blast Crisis - genetics | Mice | Thiazoles - pharmacology | Benzamides | Blast Crisis - metabolism | Fusion Proteins, bcr-abl - metabolism | Sphingosine - chemistry | Drug Resistance, Neoplasm - drug effects | Enzyme inhibitors | Analysis | Leukemia | Philadelphia chromosome
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 4, pp. 403 - 411
Journal Article
PloS one, ISSN 1932-6203, 2015, Volume 10, Issue 3, p. e0119156
Journal Article
Cancer, ISSN 0008-543X, 11/2013, Volume 119, Issue 21, pp. 3805 - 3811
BACKGROUNDThe combination of fludarabine, cyclophosphamide, and rituximab (FCR) has produced improved response rates and a prolonged survival in patients with chronic lymphocytic leukemia (CLL... 
chronic lymphocytic leukemia | combination of fludarabine, cyclophosphamide, and rituximab | cytopenia | prognosis | DIAGNOSIS | PREDICTOR | and rituximab | CHEMOIMMUNOTHERAPY | GUIDELINES | combination of fludarabine | REGIMEN | ACUTE MYELOID-LEUKEMIA | MYELODYSPLASTIC SYNDROME | MAINTENANCE | ONCOLOGY | INITIAL THERAPY | cyclophosphamide | PROGRESSION-FREE | Myeloablative Agonists - therapeutic use | Cyclophosphamide - administration & dosage | Immunotherapy - methods | Myeloablative Agonists - adverse effects | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Young Adult | Aged, 80 and over | Clinical Trials, Phase II as Topic - statistics & numerical data | Adult | Female | Leukemia, Lymphocytic, Chronic, B-Cell - blood | Retrospective Studies | Leukemia, Lymphocytic, Chronic, B-Cell - immunology | Immune Tolerance - drug effects | Pancytopenia - chemically induced | Vidarabine - adverse effects | Pancytopenia - diagnosis | Rituximab | Treatment Outcome | Vidarabine - analogs & derivatives | Leukemia, Lymphocytic, Chronic, B-Cell - epidemiology | Immunotherapy - adverse effects | Leukemia, Lymphocytic, Chronic, B-Cell - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - adverse effects | Pancytopenia - epidemiology | Adolescent | Aged | Vidarabine - administration & dosage | Pancytopenia - blood | Antibodies, Monoclonal, Murine-Derived - adverse effects | Chronic lymphocytic leukemia | Cyclophosphamide | Fludarabine | Dosage and administration | Research | Drug therapy, Combination | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
PloS one, ISSN 1932-6203, 2018, Volume 13, Issue 4, p. e0196181
.... G-banding, fluorescence in situ hybridization (FISH), and molecular genetic analyses were done on bone marrow cells from a patient with chronic lymphocytic leukemia (CLL... 
PROTEIN | GENE | T(7/21) | ALG-2 | MULTIDISCIPLINARY SCIENCES | ACUTE MYELOID-LEUKEMIA | T(7/21)(P22,Q22) | RUNX1 | Amino Acid Sequence | Translocation, Genetic | Chromosome Banding | Humans | Middle Aged | In Situ Hybridization, Fluorescence | Leukemia, Lymphocytic, Chronic, B-Cell - genetics | Sequence Analysis, DNA | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Myelodysplastic Syndromes - etiology | Chromosomes, Human, Pair 5 | Myelodysplastic Syndromes - diagnosis | Oncogene Proteins, Fusion - genetics | Apoptosis Regulatory Proteins - genetics | Female | Chromosomes, Human, Pair 21 | Core Binding Factor Alpha 2 Subunit - genetics | Calcium-Binding Proteins - genetics | Care and treatment | Transcription factors | Patient outcomes | Research | Myelodysplastic syndromes | Case studies | Complications and side effects | Chronic lymphocytic leukemia | Causes of | Genetic aspects | Diagnosis | Health aspects | Cancer | Leukemia | Genes | Genomics | Fluorescence | Myelodysplasia | Kinases | Myelodysplastic syndrome | Subgroups | Gene sequencing | Ethics | Metaphase | Genetic analysis | Fluorescence in situ hybridization | Bone marrow | Genetics | Chromosomes | Informatics | Translocation | Chronic lymphatic leukemia | DNA probes | Runx1 protein | Chromosome 5 | Lymphatic leukemia | Ribonucleic acid--RNA | Polymerase chain reaction | Hospitals | Banding | Chromosome 21 | Cytogenetics | Diagnostic systems | Chromosome aberrations | Apoptosis | RNA | Ribonucleic acid
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 2010, Volume 107, Issue 27, pp. 12210 - 12215
Journal Article